Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group—Italian Neurological Society

Natalizumab drug holiday in multiple sclerosis: Poorly Tolerated

(2010) Joep Killestein et al.   ANNALS OF NEUROLOGY

Anti-JC virus antibodies: Implications for PML Risk Stratification

(2010) Leonid Gorelik et al.   ANNALS OF NEUROLOGY

Neurologic Consequences of the Immune Reconstitution Inflammatory Syndrome (IRIS)

(2010) Micheline McCarthy et al.   Current Neurology and Neuroscience Reports

Natalizumab Reduces Clinical and MRI Activity in Multiple Sclerosis Patients with High Disease Activity: Results from a Multicenter Study in Switzerland

(2010) Norman Putzki et al.   EUROPEAN NEUROLOGY

Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases

(2010) David B Clifford et al.   LANCET NEUROLOGY

Safety and efficacy of natalizumab in children with multiple sclerosis

(2010) A. Ghezzi et al.   NEUROLOGY

Evidence Report: The efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

(2010) J. J. Marriott et al.   NEUROLOGY

The effects of natalizumab on inflammatory mediators in multiple sclerosis: prospects for treatment-sensitive biomarkers

(2009) M. Khademi et al.   EUROPEAN JOURNAL OF NEUROLOGY

Demographic and clinic characteristics of French patients treated with natalizumab in clinical practice

(2009) Olivier Outteryck et al.   JOURNAL OF NEUROLOGY

Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function

(2009) B. O. Khatri et al.   NEUROLOGY

Treatment of Progressive Multifocal Leukoencephalopathy Associated with Natalizumab

(2009) Werner Wenning et al.   NEW ENGLAND JOURNAL OF MEDICINE

Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy

(2008) O. Stuve et al.   NEUROLOGY